Marios K Georgakis is an expert in Neurology at LMU Klinikum (Germany). As of September 2026, ScienceLeadR ranks Marios K Georgakis in the top 1% of experts worldwide for Cerebrovascular Disorders. Marios K Georgakis has authored 196 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 855 (community average: 125). How the SLR is computed.

LeadR Profile

Marios K Georgakis LMU Klinikum Germany
855 ScienceLeadR Reputation 855
Network Map

Neurology

Subspecialties: Cardiology - Genetics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2016 - 2026

Source: PubMed

Ludwig-Maximilians-Universität München

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 196

Citations

Citations: 5 834 1st author: 54 Last author: 30 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Multimodal profiling of atherosclerosis: Protocol and pilot data for the AtherOMICS biobank.
PMID 42789718 — cells, pilots, biological science disciplines, macrophages, atherosclerosis, plasma
Sci Adv20261
Proteomic signatures as biomarkers of atherosclerosis burden.
PMID 42367007 — cardiovascular diseases, cardiovascular system, biomarkers, machine learning, proteomics, atherosclerosis, proteome, plasma
Cardiovasc Res20260
Lipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults.
PMID 42012308 — lipoproteins, cardiovascular diseases, phenotype, lipoprotein(a), plasma
J Clin Invest20260
Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk.
PMID 41954542 — heart failure, heart, interleukin-6
JACC Heart Fail20260
Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.
PMID 41932221 — lipoproteins, interleukin-6, arteries, lipoprotein(a)
Atherosclerosis20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 4 1

By status:

Active not recruiting 1
Completed 1

By type:

Interventional 1
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map